Heart Failure Treatment and Management
Heart failure is a clinical syndrome in which the heart cannot pump enough blood to meet the body's demands, affecting tens of millions of people worldwide and accounting for a disproportionate share of hospitalizations and healthcare costs. Cardiologists and researchers study how to diagnose the condition earlier—often using biomarkers like B-type natriuretic peptide, which rises in the blood when the heart is under strain—and how to translate evolving treatment guidelines into better survival and quality of life for patients. A persistent challenge is reducing hospital readmission rates, which remain stubbornly high despite advances in medication and monitoring, partly because outcomes are complicated by comorbidities such as impaired kidney function that blunt the effectiveness of standard therapies. Active research is focused on refining risk prediction models that can identify which patients are most likely to deteriorate, and on understanding how the growing epidemiological burden of heart failure intersects with broader cardiovascular disease trends in aging populations.
- Works
- 102,656
- Total citations
- 1,964,377
- Keywords
- Heart FailureGuidelinesDiagnosisTreatmentB-Type Natriuretic PeptideEpidemiology
Top papers in Heart Failure Treatment and Management
Ordered by total citation count.
- Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.↗ 19,545
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure↗ 12,946OA
- 2013 ACCF/AHA Guideline for the Management of Heart Failure↗ 12,625
- Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?↗ 11,735
- K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification↗ 11,656
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure↗ 11,497OA
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure↗ 9,103OA
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients↗ 8,659OA
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure↗ 8,060OA
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes↗ 7,330OA
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC↗ 6,905OA
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure↗ 6,834OA
Active researchers
Top authors in this area, ranked by h-index.